• Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

The long-distance race for a corona vaccine

Developing a vaccine takes a long time and occurs in different phases. A virus spreads quickly and unpredictably. Therefore, the outcome is a gamble for anyone in the race for the corona vaccine.
The Bill & Melinda Gates Foundation is to provide samples of 15,000 therapeutic molecules to the Gasthuisberg hospital at the University of Leuven, to aid research into therapies to combat the coronavirus COVID-19, De Standaard reports.
Earlier this year, the lab of Xavier Saelens (VIB-UGent) announced the discovery of a unique antibody that is capable of binding the virus that causes COVID-19 (SARS-CoV-2). The antibody was developed in collaboration with two research groups in the US. The team has now established that the antibody can neutralize a lab variant of the virus, an important step forward in the development of a potential antiviral drug against the new coronavirus. This progress was made possible thanks to the intensive efforts of various teams in the VIB-UGent Center for Medical Biotechnology.
Hetty Helsmoortel is a science communicator who has dedicated herself to bringing research breakthroughs to a broader audience. In her recent book “De Geknipte Genen”, she tackles CRISPR: a revolutionary gene editing technology whose applications raise tricky ethical questions. We sat down with Dr. Helsmoortel to discuss her views on CRISPR’s potential and why she feels it is so important for the public to be well informed on this technical topic.
  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Developing a vaccine takes a long time and occurs in different phases. A virus spreads quickly and unpredictably. Therefore, the outcome is a gamble for anyone in the race for the corona vaccine.
The Bill & Melinda Gates Foundation is to provide samples of 15,000 therapeutic molecules to the Gasthuisberg hospital at the University of Leuven, to aid research into therapies to combat the coronavirus COVID-19, De Standaard reports.
Earlier this year, the lab of Xavier Saelens (VIB-UGent) announced the discovery of a unique antibody that is capable of binding the virus that causes COVID-19 (SARS-CoV-2). The antibody was developed in collaboration with two research groups in the US. The team has now established that the antibody can neutralize a lab variant of the virus, an important step forward in the development of a potential antiviral drug against the new coronavirus. This progress was made possible thanks to the intensive efforts of various teams in the VIB-UGent Center for Medical Biotechnology.
Hetty Helsmoortel is a science communicator who has dedicated herself to bringing research breakthroughs to a broader audience. In her recent book “De Geknipte Genen”, she tackles CRISPR: a revolutionary gene editing technology whose applications raise tricky ethical questions. We sat down with Dr. Helsmoortel to discuss her views on CRISPR’s potential and why she feels it is so important for the public to be well informed on this technical topic.